Qi Lv et al. have shown that the suppression of HIF-1α-mediated glycolysis by costunolide acts specifically in the differentiation of Th17 cells and consequent UC relief, and it also provides a novel prospective for the immunometabolic treatment of colitis (Lv et al., 2021). Here, HIF1A is linked to colitis.